Genomics Landscape
Country
Stage
AUM
Portfolio
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| 5AM Ventures | Menlo Park, USA | biotech-focused | seedseries-a+1 | 8 |
| 7wireVentures | Chicago, USA | healthcare-focused | seedseries-a+3 | 5 |
| Abingworth | London, UK / Boston, USA | biotech-focused | seedseries-a+3 | 34 |
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |
| Alexandria Venture Investments | Pasadena, USA | cvc | seedseries-a+3 | 6 |
| Alix Ventures | San Francisco, USA | biotech-focused | seedseries-a | 0 |
| Alloy Ventures | Palo Alto, USA | generalist | seedseries-a+1 | 1 |
| Alta Partners | San Francisco, USA | biotech-focused | seedseries-a+2 | 0 |
| Altimeter Capital | Menlo Park, USA | generalist | series-cgrowth | 2 |
| aMoon | Tel Aviv, Israel | biotech-focused | series-aseries-b+2 | 8 |
| Andera Partners (BioDiscovery) | Paris, France | biotech-focused | seedseries-a+2 | 0 |
| Andreessen Horowitz (a16z) | Menlo Park, USA | generalist | seedseries-a+3 | 1 |
| Angelini Ventures | Rome, Italy | cvc | seedseries-a+2 | 4 |
| Annex Investments | Dubai, UAE | generalist | seedseries-a+2 | 2 |
| Apollo Health Ventures | Dusseldorf, Germany / Boston, USA | biotech-focused | seedseries-a+1 | 15 |
| Apple Tree Partners | New York, USA | biotech-focused | series-aseries-b+2 | 23 |
| ARCH Venture Partners | Chicago, USA | biotech-focused | seedseries-a+3 | 6 |
| Artiman Ventures | Palo Alto, USA / Bangalore, India | generalist | seedseries-a+1 | 1 |
| Atlas Venture | Cambridge, USA | biotech-focused | seedseries-a+1 | 1 |
| Baillie Gifford | Edinburgh, UK | generalist | series-cgrowth | 1 |
| Bain Capital Life Sciences | Boston, USA | biotech-focused | series-aseries-b+2 | 0 |
| Bayer (Leaps by Bayer) | Leverkusen, Germany | cvc | seedseries-a+2 | 0 |
| BECO Capital | Dubai, UAE | generalist | seedseries-a+1 | 0 |
| Bessemer Venture Partners | San Francisco, USA / Boston, USA | generalist | seedseries-a+3 | 3 |
| BioAdvance | Philadelphia, USA | biotech-focused | seedseries-a | 0 |
| BioMark Capital | San Francisco, USA | biotech-focused | seedseries-a+3 | 0 |
| Boxer Capital | San Diego, USA | biotech-focused | seedseries-a+3 | 0 |
| Breakout Ventures | San Francisco, USA | biotech-focused | seedseries-a+1 | 0 |
| Casdin Capital | New York, USA | biotech-focused | series-cgrowth | 3 |
| CE-Ventures (Crescent Enterprises) | Sharjah, UAE | generalist | seedseries-a+3 | 4 |
| Celgene (now Bristol Myers Squibb) | Summit, USA (historical) | cvc | seedseries-a+3 | 0 |
| Civilization Ventures | San Francisco, USA | biotech-focused | seedseries-a+1 | 0 |
| Communitas Capital | Boston, USA | generalist | seedseries-a+1 | 1 |
| Corundum Systems Biology | Tokyo, Japan | biotech-focused | seedseries-a+1 | 9 |
| D1 Capital Partners | New York, USA | generalist | series-cgrowth | 1 |
| Deerfield Management | New York, USA | biotech-focused | seedseries-a+3 | 3 |
| DFJ Growth | Menlo Park, USA | generalist | series-cgrowth | 1 |
| Dragoneer Investment Group | San Francisco, USA | generalist | series-cgrowth | 1 |
| DST Global | Hong Kong / London | generalist | series-cgrowth | 1 |
| Emirates Angels | Dubai, UAE | generalist | seed | 0 |
| Entree Capital | Tel Aviv, Israel / New York, USA | generalist | seedseries-a+1 | 2 |
| F-Prime Capital | Cambridge, USA | biotech-focused | seedseries-a+2 | 2 |
| Felicis Ventures | Menlo Park, USA | generalist | seedseries-a+1 | 1 |
| Fifty Years | San Francisco, USA | biotech-focused | seedseries-a | 0 |
| First Round Capital | San Francisco, USA / New York, USA | generalist | seed | 1 |
| Flagship Pioneering | Cambridge, USA | biotech-focused | seedseries-a+3 | 1 |
| Forbion | Naarden, Netherlands | biotech-focused | seedseries-a+3 | 0 |
| Foresite Capital | San Francisco, USA | biotech-focused | series-aseries-b+2 | 3 |
| Founders Fund | San Francisco, California, USA | generalist | seedseries-a+3 | 1 |
| Franklin Templeton Investments | San Mateo, California, USA | generalist | growth | 1 |
| G42 Healthcare | Abu Dhabi, UAE | cvc | series-aseries-b+2 | 1 |
| General Atlantic | New York, New York, USA | pe | growth | 1 |
| General Catalyst | Cambridge, Massachusetts, USA | generalist | seedseries-a+3 | 2 |
| Gilde Healthcare | Utrecht, Netherlands | biotech-focused | series-aseries-b+2 | 0 |
| GV (Google Ventures) | Mountain View, California, USA | cvc | seedseries-a+3 | 3 |
| Hatteras Venture Partners | Durham, North Carolina, USA | biotech-focused | seedseries-a+1 | 0 |
| HealthCap | Stockholm, Sweden | biotech-focused | seedseries-a+3 | 0 |
| Hedosophia | London, United Kingdom | pe | growth | 1 |
| Icon Ventures | Palo Alto, California, USA | generalist | series-aseries-b+2 | 1 |
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |
| Indaco Venture Partners | Milan, Italy | generalist | seedseries-a+1 | 0 |
| JIMCO Life Sciences Fund | Abu Dhabi, UAE | biotech-focused | series-aseries-b+2 | 0 |
| K9 Ventures | Palo Alto, California, USA | generalist | seed | 1 |
| Khosla Ventures | Menlo Park, California, USA | generalist | seedseries-a+3 | 2 |
| Kleiner Perkins | Menlo Park, California, USA | generalist | seedseries-a+3 | 4 |
| Kurma Partners | Paris, France | biotech-focused | seedseries-a+2 | 0 |
| L1 Digital | Zurich, Switzerland | dao | seedseries-a | 1 |
| LifeX Ventures | Boston, Massachusetts, USA | biotech-focused | seedseries-a+1 | 0 |
| Lightspeed Venture Partners | Menlo Park, California, USA | generalist | seedseries-a+3 | 3 |
| Lightstone Ventures | Boston, Massachusetts, USA | biotech-focused | seedseries-a+2 | 0 |
| Linden Lake Venture Capital | New York, New York, USA | generalist | seedseries-a | 1 |
| EQT Life Sciences (formerly LSP) | Munich, Germany | biotech-focused | seedseries-a+3 | 0 |
| Lundbeckfonden BioCapital | Copenhagen, Denmark | biotech-focused | seedseries-a+3 | 0 |
| Lux Capital | New York, New York, USA | biotech-focused | seedseries-a+3 | 2 |
| M Ventures | Amsterdam, Netherlands | cvc | seedseries-a+3 | 0 |
| March Capital | Santa Monica, California, USA | generalist | series-aseries-b+2 | 1 |
| Mayfield | Menlo Park, California, USA | generalist | seedseries-a+2 | 1 |
| Medicxi | London, United Kingdom | biotech-focused | seedseries-a+2 | 0 |
| Mike Jafar Family Office | United States | family-office | series-aseries-b+1 | 0 |
| MPM BioImpact | Boston, Massachusetts, USA | biotech-focused | seedseries-a+3 | 0 |
| Mubadala Capital | Abu Dhabi, UAE | pe | series-bseries-c+1 | 1 |
| NEA (New Enterprise Associates) | Menlo Park, California, USA | generalist | seedseries-a+3 | 1 |
| Novartis Venture Fund | Basel, Switzerland | cvc | seedseries-a+2 | 0 |
| Novo Holdings | Hellerup, Denmark | biotech-focused | seedseries-a+3 | 13 |
| Oak HC/FT | Greenwich, Connecticut, USA | generalist | series-aseries-b+2 | 1 |
| Omega Funds | Boston, Massachusetts, USA | biotech-focused | seedseries-a+3 | 0 |
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |
| OrbiMed | New York, New York, USA | biotech-focused | seedseries-a+3 | 1 |
| Oxford Science Enterprises | Oxford, United Kingdom | biotech-focused | seedseries-a+2 | 1 |
| Panakes Partners | Milan, Italy | biotech-focused | seedseries-a+2 | 0 |
| Perceptive Advisors | New York, New York, USA | biotech-focused | series-aseries-b+2 | 0 |
| Petrillo Capital | United States | generalist | series-aseries-b+1 | 0 |
| Pfizer Ventures | New York, New York, USA | cvc | seedseries-a+2 | 1 |
| Playground Global | - | generic | - | 1 |
| Polaris Partners | US | biotech-focused | - | 33 |
| Portal Innovations | US | biotech-focused | - | 13 |
| RA Capital Management | US | biotech-focused | seedseries-a+3 | 0 |
| Redmile Group | - | healthcare-focused | - | 1 |
| Revolution Growth | Washington, DC, USA | generalist | series-bseries-c+1 | 1 |
| RiverVest Venture Partners | St. Louis, Missouri, USA | biotech-focused | seedseries-a+2 | 0 |
| Salica Investments | London, UK & Abu Dhabi, UAE | generalist | series-aseries-b+1 | 2 |
| Sanofi Ventures | Cambridge, Massachusetts, USA | cvc | seedseries-a+3 | 1 |
| Section 32 | Burlingame, California, USA | biotech-focused | seedseries-a+3 | 1 |
| Sequoia Capital | Menlo Park, California, USA | generalist | seedseries-a+3 | 4 |
| Seroba Life Sciences | Dublin, Ireland | biotech-focused | seedseries-a+1 | 0 |
| Seventure Partners | Paris, France | biotech-focused | seedseries-a+2 | 0 |
| Shine Capital | New York, New York, USA | generalist | seedseries-a | 1 |
| Silver Lake | Menlo Park, California, USA | pe | growth | 1 |
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |
| SoftBank Vision Fund | Tokyo, Japan & London, UK | generalist | series-bseries-c+1 | 2 |
| SoftTech VC | Palo Alto, California, USA | generalist | seedseries-a | 1 |
| Spur Capital Partners | Boston, Massachusetts, USA | pe | growth | 1 |
| SR One | Philadelphia, Pennsylvania, USA & London, UK | biotech-focused | seedseries-a+2 | 0 |
| StepStone Group | New York, New York, USA | pe | growth | 1 |
| Sugati Ventures | Dubai, UAE | biotech-focused | seedseries-a+1 | 0 |
| Sunstone Life Science Ventures | Copenhagen, Denmark | biotech-focused | seedseries-a+2 | 0 |
| Sutter Hill Ventures | Palo Alto, California, USA | generalist | seedseries-a+3 | 1 |
| SV Health Investors | Boston, Massachusetts, USA & London, UK | biotech-focused | seedseries-a+3 | 0 |
| T. Rowe Price | Baltimore, Maryland, USA | hedge-fund | growth | 1 |
| The Column Group | San Francisco, California, USA | biotech-focused | seedseries-a+3 | 1 |
| Third Rock Ventures | Boston, Massachusetts, USA | biotech-focused | seedseries-a+2 | 4 |
| TMC Venture Fund | Houston, Texas, USA | biotech-focused | seedseries-a+1 | 0 |
| TPG Biotech | San Francisco, California, USA | biotech-focused | series-bseries-c+1 | 1 |
| TVM Capital Healthcare | Dubai, UAE & Munich, Germany | biotech-focused | series-aseries-b+1 | 10 |
| V-Bio Ventures | Ghent, Belgium | biotech-focused | seedseries-a+1 | 0 |
| Valiance Asset Management | New York, New York, USA | hedge-fund | growth | 1 |
| venBio Partners | San Francisco, California, USA | biotech-focused | seedseries-a+3 | 0 |
| Venrock | Palo Alto, California, USA & New York, New York, USA | biotech-focused | seedseries-a+3 | 1 |
| Versant Ventures | San Francisco, California, USA & Basel, Switzerland | biotech-focused | seedseries-a+3 | 1 |
| Vertex Pharmaceuticals | Boston, Massachusetts, USA | cvc | series-aseries-b+2 | 1 |
| VG Acquisition Corp | New York, New York, USA | generalist | growth | 1 |
| Vida Ventures | Los Angeles, California, USA & Boston, Massachusetts, USA | biotech-focused | seedseries-a+3 | 0 |
| VitaDAO | Decentralized (Global) | dao | seed | 7 |
| Vivo Capital | Palo Alto, California, USA & Shanghai, China | biotech-focused | seedseries-a+3 | 0 |
| Warburg Pincus | New York, New York, USA | pe | growth | 1 |
| Wellington Partners Life Sciences | Munich, Germany | biotech-focused | seedseries-a+2 | 0 |
| Ysios Capital | Barcelona, Spain | biotech-focused | seedseries-a+3 | 0 |